1. Home
  2. INLF vs SPRC Comparison

INLF vs SPRC Comparison

Compare INLF & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INLF

INLIF LIMITED

HOLD

Current Price

$0.11

Market Cap

2.2M

Sector

Industrials

ML Signal

HOLD

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

HOLD

Current Price

$6.97

Market Cap

2.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INLF
SPRC
Founded
2016
2004
Country
China
Israel
Employees
156
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.5M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
INLF
SPRC
Price
$0.11
$6.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.9M
1.4M
Earning Date
03-06-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.46
52 Week High
$5.20
$15.79

Technical Indicators

Market Signals
Indicator
INLF
SPRC
Relative Strength Index (RSI) 20.71 45.70
Support Level N/A $3.46
Resistance Level $0.66 $8.97
Average True Range (ATR) 0.72 1.39
MACD -0.49 -0.37
Stochastic Oscillator 0.16 2.02

Price Performance

Historical Comparison
INLF
SPRC

About INLF INLIF LIMITED

INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. Its portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: